NZ561374A - Polymyxin B analogs for LPS detoxification - Google Patents
Polymyxin B analogs for LPS detoxificationInfo
- Publication number
- NZ561374A NZ561374A NZ561374A NZ56137406A NZ561374A NZ 561374 A NZ561374 A NZ 561374A NZ 561374 A NZ561374 A NZ 561374A NZ 56137406 A NZ56137406 A NZ 56137406A NZ 561374 A NZ561374 A NZ 561374A
- Authority
- NZ
- New Zealand
- Prior art keywords
- peptide
- lps
- leu
- cys2
- saep
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05300270A EP1712559A1 (en) | 2005-04-11 | 2005-04-11 | Polymyxin B analogs for LPS detoxification |
| EP05300319 | 2005-04-26 | ||
| PCT/EP2006/003237 WO2006108586A2 (en) | 2005-04-11 | 2006-04-10 | Polymyxin b analogs for lps detoxification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ561374A true NZ561374A (en) | 2009-02-28 |
Family
ID=36968822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ561374A NZ561374A (en) | 2005-04-11 | 2006-04-10 | Polymyxin B analogs for LPS detoxification |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1871787A2 (pt) |
| JP (1) | JP2008537749A (pt) |
| KR (1) | KR20070118646A (pt) |
| AU (1) | AU2006233634A1 (pt) |
| BR (1) | BRPI0610701A2 (pt) |
| CA (1) | CA2603850A1 (pt) |
| IL (1) | IL186322A0 (pt) |
| MX (1) | MX2007012457A (pt) |
| NO (1) | NO20075753L (pt) |
| NZ (1) | NZ561374A (pt) |
| WO (1) | WO2006108586A2 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2032161B1 (en) | 2006-06-12 | 2012-07-11 | GlaxoSmithKline Biologicals S.A. | L3v los vaccines |
| CA2761924C (fr) | 2009-05-14 | 2017-10-31 | Sanofi Pasteur | Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6 |
| NZ597004A (en) | 2009-05-14 | 2013-03-28 | Sanofi Pasteur | Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria |
| TWI548746B (zh) * | 2009-08-06 | 2016-09-11 | 英特威特國際股份有限公司 | 防備豬胸膜肺炎之疫苗及製備該疫苗之方法 |
| CN111511910A (zh) * | 2017-12-22 | 2020-08-07 | 韩美药品株式会社 | 具有新颖结构的治疗酶融合蛋白及其用途 |
| US20230287048A1 (en) * | 2020-03-20 | 2023-09-14 | HLB Science Inc. | Composition and kit for removing lipopolysaccharide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5371186A (en) * | 1991-02-11 | 1994-12-06 | Biosynth S.R.L. | Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
| WO2004052394A1 (en) * | 2002-12-06 | 2004-06-24 | Biosynth S.R.L. | Broad-spectrum lps based vaccines of unencapsulated strains of haemophilus influenzae and other pathogenic species of gram-negative bacteria |
-
2006
- 2006-04-10 WO PCT/EP2006/003237 patent/WO2006108586A2/en not_active Application Discontinuation
- 2006-04-10 BR BRPI0610701-0A patent/BRPI0610701A2/pt not_active IP Right Cessation
- 2006-04-10 JP JP2008505786A patent/JP2008537749A/ja active Pending
- 2006-04-10 KR KR1020077023738A patent/KR20070118646A/ko not_active Application Discontinuation
- 2006-04-10 NZ NZ561374A patent/NZ561374A/en not_active IP Right Cessation
- 2006-04-10 EP EP06724173A patent/EP1871787A2/en not_active Withdrawn
- 2006-04-10 MX MX2007012457A patent/MX2007012457A/es not_active Application Discontinuation
- 2006-04-10 AU AU2006233634A patent/AU2006233634A1/en not_active Abandoned
- 2006-04-10 CA CA002603850A patent/CA2603850A1/en not_active Abandoned
-
2007
- 2007-09-25 IL IL186322A patent/IL186322A0/en unknown
- 2007-11-09 NO NO20075753A patent/NO20075753L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070118646A (ko) | 2007-12-17 |
| AU2006233634A1 (en) | 2006-10-19 |
| EP1871787A2 (en) | 2008-01-02 |
| JP2008537749A (ja) | 2008-09-25 |
| CA2603850A1 (en) | 2006-10-19 |
| BRPI0610701A2 (pt) | 2010-07-20 |
| WO2006108586A3 (en) | 2006-12-14 |
| MX2007012457A (es) | 2007-12-10 |
| WO2006108586A2 (en) | 2006-10-19 |
| IL186322A0 (en) | 2008-01-20 |
| NO20075753L (no) | 2007-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kabanova et al. | Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate | |
| KR100593466B1 (ko) | 다당류-펩타이드접합체 | |
| KR101573648B1 (ko) | 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물 | |
| US20010048929A1 (en) | Novel multi-oligosaccharide glycoconjugate bacterial meningitis vaccines | |
| NZ561374A (en) | Polymyxin B analogs for LPS detoxification | |
| JP7485771B2 (ja) | ＦｉｍＨ変異体、その組成物、及びその使用 | |
| JP2011504487A (ja) | アジュバント添加されたグルカン | |
| DE69714011T2 (de) | Die erzeugung einer immunantwort gegen erwünschte determinanten | |
| US7588765B2 (en) | Polysaccharide and glycoconjugate vaccines | |
| US6951652B2 (en) | Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases | |
| WO2016012587A1 (en) | Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria | |
| US20190389894A1 (en) | Novel semi-synthetic meningococcal conjugate vaccine | |
| KR20030096369A (ko) | 저분자량 하이알루론산과 폴리펩티드 독소의 면역원성접합체 | |
| EP1712559A1 (en) | Polymyxin B analogs for LPS detoxification | |
| US7507718B2 (en) | Polymyxin B analogs for LPS detoxification | |
| Kihlberg et al. | Use of carbohydrates and peptides in studies of adhesion of pathogenic bacteria and in efforts to generate carbohydrate-specific T cells | |
| WO2004052394A1 (en) | Broad-spectrum lps based vaccines of unencapsulated strains of haemophilus influenzae and other pathogenic species of gram-negative bacteria | |
| CN112603996A (zh) | 一种脂磷壁酸疫苗制剂及其应用 | |
| Velucchi et al. | A model of Meisseria meningitidis | |
| MXPA98007617A (es) | Conjugados de polisacaridos peptidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| LAPS | Patent lapsed |